Design and Synthesis of Potent and Selective BACE-1 Inhibitors

被引：26

作者：

Bjorklund, Catarina ^{[1
]}

Oscarson, Stefan ^{[1
,2
]}

Benkestock, Kurt ^{[3
]}

Borkakoti, Neera ^{[3
]}

Jansson, Katarina ^{[3
]}

Lindberg, Jimmy ^{[3
]}

Vrang, Lotta ^{[3
]}

Hallberg, Anders ^{[4
]}

Rosenquist, Asa ^{[3
]}

Samuelsson, Bertil ^{[1
,3
]}

机构：

[1] Stockholm Univ, Arrhenius Lab, Dept Organ Chem, SE-10691 Stockholm, Sweden

[2] UCD, Sch Chem & Chem Biol, Dublin 4, Ireland

[3] Medivir AB, SE-14122 Huddinge, Sweden

[4] Uppsala Univ, Dept Med Chem, BMC, SE-75123 Uppsala, Sweden

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2010年 / 53卷 / 04期

关键词：

HIV-1 PROTEASE INHIBITORS; BETA-SECRETASE; ALZHEIMERS-DISEASE; ASPARTIC PROTEASE; PLASMEPSIN-II; CATHEPSIN-D; BRAIN; MICE;

D O I：

10.1021/jm901168f

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Highly potent BACE-1 protease inhibitors have been developed from ill inhibitors containing a hydroxyethylene (HE) core displaying aryloxymethyl or benzyloxymethyl P1 side chain and a methoxy P1' side chain. The target molecules were synthesized in good overall yields from chiral carbohydrate starting materials. The inhibitors show high BACF-1 potency and good selectivity against cathepsin D, where the most potent inhibitor Furnishes BACE-1 Ki << 1 nM and displays > 1000-fold selectivity over cathepsin D.

引用

页码：1458 / 1464

页数：7

共 34 条

[1] Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: Exploration of P1 phenoxy and benzyloxy residues
Back, Marcus
Nyhlen, Jonas
Kvarnstrom, Ingemar
Appelgren, Sara
Borkakoti, Neera
Jansson, Katarina
Lindberg, Jimmy
Nystrom, Susanne
Hallberg, Anders
Rosenquist, Asa
Samuelsson, Bertil
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (21) : 9471 - 9486
[2] CRYSTAL-STRUCTURES OF NATIVE AND INHIBITED FORMS OF HUMAN CATHEPSIN-D - IMPLICATIONS FOR LYSOSOMAL TARGETING AND DRUG DESIGN
BALDWIN, ET
BHAT, TN
GULNIK, S
HOSUR, MV
SOWDER, RC
CACHAU, RE
COLLINS, J
SILVA, AM
ERICKSON, JW
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) : 6796 - 6800
[3] Protease inhibitors as potential disease-modifying therapeutics for Alzheimer's disease
Beher, D
Graham, SL
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (11) : 1385 - 1409
[4] Alzheimer's disease
Scheltens, Philip
De Strooper, Bart
Kivipelto, Miia
Holstege, Henne
Chetelat, Gael
Teunissen, Charlotte E.
Cummings, Jeffrey
van der Flier, Wiesje M.
[J]. LANCET, 2021, 397 (10284) : 1577 - 1590
[5] LITHIATED 5-TOSYLPROPANAL AND 4-TOSYL-2-BUTANONE DIMETHYL ACETALS AS BETA-ACYLVINYL ANION EQUIVALENTS FOR THE SYNTHESIS OF UNSATURATED 1,4-DICARBONYL COMPOUNDS AND ALPHA,BETA-BUTENOLIDES
BONETE, P
NAJERA, C
[J]. TETRAHEDRON, 1995, 51 (09) : 2763 - 2776
[6] Rational design and synthesis of selective BACE-1 inhibitors
Brady, SF
Singh, S
Crouthamel, MC
Holloway, MK
Coburn, CA
Garsky, VM
Bogusky, M
Pennington, MW
Vacca, JP
Hazuda, D
Lai, MT
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (03) : 601 - 604
[7] BACE-1 inhibition by a series of ψ[CH2NH] reduced amide isosteres
Coburn, CA
Stachel, SJ
Jones, KG
Steele, TG
Rush, DM
DiMuzio, J
Pietrak, BL
Lai, MT
Huang, Q
Lineberger, J
Jin, LX
Munshi, S
Holloway, MK
Espeseth, A
Simon, A
Hazuda, D
Graham, SL
Vacca, JP
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (14) : 3635 - 3638
[8] Aspartic proteases in drug discovery
Eder, Joerg
Hommel, Ulrich
Cumin, Frederic
Martoglio, Bruno
Gerhartz, Bernd
[J]. CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (03) : 271 - 285
[9] Recent developments of structure based β-secretase inhibitors for Alzheimer's disease
Ghosh, AK
Kumaragurubaran, N
Tang, J
[J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (16) : 1609 - 1622
[10] Structure-based design:: Potent inhibitors of human brain memapsin 2 (β-secretase)
Ghosh, AK
Bilcer, G
Harwood, C
Kawahama, R
Shin, D
Hussain, KA
Hong, L
Loy, JA
Nguyen, C
Koelsch, G
Ermolieff, J
Tang, J
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (18) : 2865 - 2868

← 1 2 3 4 →